bioRxivImmunology
Mucosal associated invariant T cells are altered in patients with Hidradenitis Suppurativa and contribute to the inflammatory milieu
C. Gallagher, J. MacMahon, C. O'Neill, F. C. Cassidy, H. Dunbar, C. DeBarra, C. Cadden, M. M. Pisarska, N. A. Wood, J. C. Masterson, E. N. McNamee, K. English, D. O'Shea, A.-M. Tobin, A. E. Hogan
Abstract
Mucosal Associated Invariant T cells are a population of "innate" T cells, which express the invariant T cell receptor (TCR) chain V 7.2-J 33 and are capable of robust rapid cytokine secretion, producing a milieu of cytokines including IFN-{gamma} and IL-17. MAIT cells have been reported in multiple human tissues including the gut, periphery and skin. On-going research has highlighted their involvement in numerous inflammatory diseases ranging from rheumatoid arthritis and obesity to psoriasis. Hidradenitis Suppurativa (H.S) is a chronic inflammatory disease of the hair follicles, resulting in painful lesions of apocrine-bearing skin. Several inflammatory cytokines have been implicated in the pathogenesis of H.S including IL-17. The role of MAIT cells in H.S is currently unknown. In this study we show for the first time, that MAIT cells are altered in the peripheral blood of patients with H.S, with reduced frequencies and an IL-17 cytokine bias. We show that CCL20 expression is elevated in lesions of patients with H.S, and MAIT cells can actively traffic towards lesions via CCL20. We show that MAIT cells can accumulate in the lesions from patients with H.S. when compared to adjacent skin, with an IL-17 bias. We show that elevated IL-17, can be linked to the activation of dermal fibroblasts, promoting the expression of chemotactic signals including CCL20 and CXCL1. Finally, we show that targeting the IL-17A transcription factor RORyt robustly reduces IL-17 production by MAIT cells from patients with H.S. Collectively our data details IL-17 producing MAIT cells as a novel player in the pathogenesis of H.S and highlights the potential of RORyt inhibition as a novel therapeutic strategy.
- organism: human
- assay: proteomics
- assay: flow cytometry
- assay: metagenomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mass cytometry identifies dysregulation of circulating and cutaneous immune cells in patients with hidradenitis suppurativa
P. Dimitrion, I. Hamzavi, … Q.-S. Mi·bioRxiv·Jan 27, 2023
- NK and NKT cells in the pathogenesis of Hidradenitis suppurativa: Novel therapeutic strategy through targeting of CD2
M. P. Kashyap, B. Mishra, … C. Raman·bioRxiv·Oct 31, 2023
- Disease context dictates the cellular targets of IL-17 in inflammatory skin disease
Kellen J. Cavagnero, Fengwu Li, … Richard L. Gallo·Journal of Investigative DermatologyPeer-reviewed·Jul 1, 2026
- Mucosal-associated invariant T cells support IL-15-dependent Treg response in skin injury and promote resolution of skin inflammation
Grace E. Crossland, Andre Armero, … Sladjana Skopelja‐Gardner·bioRxiv·Jul 1, 2026
- Hair follicle stem cell fate supports distinct clinical endotypes in Hidradenitis Suppurativa
Audrey Onfroy, Francette Jean‐Louis, … Sophie Hüe·Journal of the European Academy of Dermatology and VenereologyPeer-reviewed·Nov 6, 2025
- Pathogenic Keratinocyte States and Fibroblast Niches Define the Tissue Microenvironment in Severe Hidradenitis Suppurativa
Xinyi Du-Harpur, Clarisse Gânier, … Fiona M. Watt·bioRxiv·Nov 11, 2025